Products
Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Vitamin B12 test kit

Abrocitinib

Cat. No.: OB0125LY-078
Appearance: Solid
Purity: 99.9%
Identity: Confirmed by NMR and HPLC.
Size:
Abrocitinib
Add to basket

Product Overview

Description: Abrocitinib is a specific and orally-active JAK1 inhibitor that interferes with cytokine signaling by inhibiting JAK1 to modulate immune cell function.
Synonym: 1622902-68-4; PF-04965842; Cibinqo; N-[cis-3-[Methyl (7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl]propane-1-sulfonamide; N-[3-[Methyl (7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl]propane-1-sulfonamide; 1-Propanesulfonamide, N-(cis-3-(methyl-7H-pyrrolo (2,3-d)pyrimidin-4-ylamino)cyclobutyl)-; N-(3-(Methyl (7H-pyrrolo (2,3-d)pyrimidin-4-yl)amino)cyclobutyl)propane-1-sulfonamide, cis-; N-(cis-3-(Methyl (7H-pyrrolo (2,3-d)pyrimidin-4-yl)amino)cyclobutyl)-propane-1-sulfonamide
CAS No.: 1622902-68-4
Compound CID: 78323835
Formula: C14H21N5O2S
Formula Weight: 323.41

Specification

Targets & IC50: JAK2: 803 nM; JAK1: 29 nM; TYK2: 1253 nM
Relative Density: 1.36 g/cm3
Stability: 3 years in powder form.
Storage: Storage at -20°C.
Applications: Abrocitinib can be used for drug development for immune-related diseases.

Library Information

Targets: JAK
Receptors: JAK; JAK1; JAK2
Pathways: Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem cells
Plate Number: AOCL-18
Plate Location: e11
Empty Location: a1-h1; a12-h12
Container: 96-well plate
Formulation: 10 mM DMSO
DMSO Max Solubility: 120 mg/mL; 371.05 mM
ALogP: 1.101
HBA_Count: 4
HBD_Count: 2
Rotatable Bond: 6
Inquiry
0
Inquiry Basket

Copyright © Protheragen. All rights reserves.